Multiple sclerosis, vitamin D, and HLA-DRB1*15

Area of Science:

• Neuroimmunology
• Environmental Medicine

Background:

• Multiple sclerosis (MS) exhibits a geographic distribution inversely correlated with ultraviolet radiation, suggesting a role for vitamin D.
• Genetic factors, particularly the major histocompatibility complex, contribute significantly to MS susceptibility, yet a portion of the risk remains unexplained.
• Gene-environment interactions are hypothesized to account for the remaining MS risk and may be key to disease prevention.

Purpose of the Study:

• To explore the role of vitamin D in the etiology and pathogenesis of multiple sclerosis.
• To investigate gene-environment interactions, specifically involving vitamin D and MS susceptibility genes.
• To assess the potential of vitamin D supplementation for MS prevention.

Main Methods:

• Review of recent studies on vitamin D levels in MS patients and controls.
• Examination of gene-environment interactions, including vitamin D and the HLA-DRB1*1501 allele.
• Analysis of twin studies investigating genetic regulation of vitamin D metabolism in MS.

Main Results:

• Vitamin D levels are significantly lower in individuals with MS compared to healthy controls.
• A gene-environment interaction between vitamin D and the MS-associated HLA-DRB1*1501 allele has been identified.
• Genetic variations in vitamin D metabolism genes (1alpha-hydroxylase, vitamin D receptor) may influence vitamin D levels and MS pathogenesis.

Conclusions:

• Gene-environment interactions, particularly involving vitamin D, may explain a portion of the missing genetic risk for MS.
• There is a critical need to investigate whether vitamin D supplementation can reduce the risk of developing MS.
• Future research in prospective cohorts and animal models is essential to clarify the timing and tissue-specific mechanisms of vitamin D's role in MS.